Log In
Print
BCIQ
Print
Print this Print this
 

setrobuvir (RG7790) (formerly ANA598)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionOral non-nucleoside non-structural protein 5B (NS5B) polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionNon-nucleoside polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today